Advisory Board

 
 
 
 

Dr. Kai Sohn, Fraunhofer IGB

Dr. Kai Sohn is Head of In-Vitro Diagnostics at Fraunhofer IGB and an expert in translational research and assay development. He brings deep expertise in oncology and non-oncology diagnostics and advises PRELIQX on clinical development, innovation strategy, and regulatory pathways.

 
 

Prof. Dr. med. Mario Schiffer, MBA, University Hospital Erlangen

Prof. Dr. med. Mario Schiffer is a leading expert in internal medicine and nephrology with over 24 years of experience. He is the Clinic Director at the University Hospital Erlangen. As a member of PRELIQX’s advisory board, he brings invaluable expertise in translational research and clinical strategy.

 
 

Dr. Jörg Hoheisel, German Cancer Research Center

Dr. Jörg Hoheisel is a leading expert in pancreatic disease research, specializing in advanced diagnostic and therapeutic approaches. With decades of experience in translational research, he brings invaluable expertise to PRELIQX, supporting our mission in precision diagnostics for pancreatic diseases.

 
 

Prof. Dr. Hakho Lee, Harvard Medical School

Dr. Lee’s  research at Massachusetts General Hospital focuses on developing advanced technologies, and point-of-care diagnostics. With deep expertise in cutting-edge diagnostic technologies, Dr. Lee contributes to PRELIQX’s mission by advancing innovative liquid biopsy solutions for kidney and pancreatic disease diagnostics.